Good point, Ohm20. But if safety (of all things) i
Post# of 148187
Seems 'safety' should apply across the board for every investigative study, or - once 'proven' safe - for none at all.
To me, nothing explains the actions of the FDA except BP collusion and corruption. Their decisions on what new drugs to approve vs those they don't follow just one rule: BP drugs in, competing drugs that threaten BP profits are out.